TY  - GEN 
AU  - Blaya Cánovas, José Lucas
AU  - Griñán Lisón, Carmen
AU  - Blancas López-Barajas, María Isabel
AU  - Marchal Corrales, Juan Antonio
AU  - Ramírez Tortosa, César Luis
AU  - López Tejada, Araceli
AU  - Benabdellah, Karim
AU  - Cortijo Gutiérrez, Marina
AU  - Cano Cortes, María Victoria
AU  - Graván, Pablo
AU  - Navarro Marchal, Saul Abenhamar
AU  - Gómez-Morales, Jaime
AU  - Calahorra, Jesús
AU  - Rodríguez-González, Carlos J.
AU  - Gallart Aragón, Tania
AU  - Sánchez Martín, Rosario María
AU  - Granados Principal, Sergio
PY  - 2024
UR  - https://hdl.handle.net/10481/94672
AB  - Background: Active targeting by surface-modified nanoplatforms enables a more precise and elevated accumulation of nanoparticles within the tumor, thereby enhancing drug delivery and efficacy for a successful cancer treatment. However, surface...
LA  - eng
PB  - BMC
KW  - Biomimetic nanoparticles
KW  - Immune checkpoint
KW  - Immune evasion
KW  - Immunotherapy
KW  - PD1
KW  - PDL1
KW  - Patient-derived xenograft
KW  - T-cell exhaustion
KW  - Triple-negative breast cancer
TI  - Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy
DO  - 10.1186/s12943-024-01997-x
ER  -